Skip to main content
Diane Havlir, MD, Infectious Disease, San Francisco, CA

Diane V Havlir MD


Professor, Medicine, University of California, San Francisco, School

Join to View Full Profile
  • 995 Potrero AveBldg 80 Ward 84San Francisco, CA 94110

  • Phone+1 415-476-4082

  • Fax+1 415-502-2992

Are you Dr. Havlir?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Diane Havlir, MD is an infectious disease specialist in San Francisco, California. She is currently licensed to practice medicine in California and Ohio. She is a Professor at University of California.

Education & Training

  • Case Western Reserve University/University Hospitals Cleveland Medical Center
    Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Infectious Disease, 1988 - 1990
  • University of California (San Francisco)
    University of California (San Francisco)Internship, Internal Medicine, 1984 - 1985
  • Duke University School of Medicine
    Duke University School of MedicineClass of 1984

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1986 - 2025
  • OH State Medical License
    OH State Medical License 1988 - 1990
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Infectious Disease
    American Board of Internal Medicine Infectious Disease

Publications & Presentations

PubMed

Press Mentions

  • Ensitrelvir Reduced the Risk for COVID-19 by 67%
    Ensitrelvir Reduced the Risk for COVID-19 by 67%March 12th, 2025
  • A Blueprint for More Equitable Care in Public Health Crises
    A Blueprint for More Equitable Care in Public Health CrisesDecember 7th, 2022
  • Breakthrough COVID Research. Vital Health Care for Locals. And Now It Risks Closure
    Breakthrough COVID Research. Vital Health Care for Locals. And Now It Risks ClosureOctober 15th, 2022
  • Join now to see all

Grant Support

  • San Francisco Bay Clinical Trials Unit (CTU)PUBLIC HEALTH FOUNDATION ENTERPRISES2007–2027
  • San Francisco Bay Clinical Trials Unit (CTU)PUBLIC HEALTH FOUNDATION ENTERPRISES2007–2027
  • San Francisco Bay Clinical Trials Unit (CTU)PUBLIC HEALTH FOUNDATION ENTERPRISES2007–2027
  • A Multisectoral Strategy to Address Persistent Drivers of the HIV Epidemic in East AfricaUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2020–2026
  • Training in HIV Translational ResearchUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2005–2026
  • Training in HIV Translational ResearchUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2005–2026
  • Training in HIV Translational ResearchUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2005–2026
  • Strategic antiretroviral therapy and HIV testing for youth in rural AfricaUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2018–2025